Prevalence in hypothyroid and its association with cardiometabolic risk factor argentine adult women
DOI:
https://doi.org/10.14306/renhyd.19.3.157Keywords:
Thyroid evaluation, Menopause, Nutritional assessment, Cardiometabolic risk factorsAbstract
Introduction: It is known that hypothyroidism is associated with cardiometabolic risk factors (CRF) as well as age, female gender. The main objective was determine the prevalence of hypothyroidism and its association with cardiometabolic risk factors in adult women attending the Foundation for Endocrine Metabolic Diseases Research of the Autonomous City of Buenos Aires, Argentina.
Material and Methods: Cross-sectional and observational design. Probabilistic sample of 316 adult women (40-65 years), randomized into two groups: hypothyroid controlled with pharmacological treatment and euthyroid. Variable: the following were studied CRF: body mass index (BMI), normal <25kg/m2 and increased ≥25.0kg/m2; waist circumference (WC) normal ≤88cm and increased >88cm; biological stage (premenopausal and postmenopausal), smoking, sedentary lifestyle; altered lipid profile (TC>200mg/dl; LDL>130mg/dl; Tg>150mg/dl; HDL-c<40mg/dl); HT≥120/80mmHg and increased fasting glucose >100mg/dl. Statistics with SPSS 15.0 establishing measures of central tendency, ANOVA and OR with 95% confidence intervals (CI) and difference of proportions with p<0.05.
Results: The 46.2% of the sample were women controlled hypothyroid and euthyroid 53.8%. The 64.2% were postmenopausal, 68% overweight or obese and 45.2% with WC increased. Age was similar in both groups: 53.3 (SD=6.4) years the hypothyroid and 53.9 (SD=6.6) years theeuthyroid. The inactivity was the CFR more prevalent in both groups. The hypothyroid women had a significantly higher risk for BMI increased (OR=0.36; 95%CI=0.21-0.59; p=0.0001) and WC altered (OR=0.53; 95%CI=0.34-0.84; p=0.006) with respect to the euthyroid women.
Conclusions: Found a prevalence of hypothyroidism in approximately half of the sample. The altered nutritional status CRF was the only significantly associated with hypothyroidism.
References
(1) Habra M, Sarlis NJ. Thyroid and aging. Rev Endocr Metab Disord. 2005; 6(2): 145–54.
(2) Hunter I, Greene SA, MacDonald TM, Morris AD. Prevalence and aetiology of hypothyroidism in the young. Arch Dis Chile. 2000; 83(3): 207–10.
(3) Zárate A, Saucedo R, Basurto L, Hernández–Valencia M. Principales problemas de salud en la mujer adulta. Acta Med Gpo Ang. 2006; 4: 57–60.
(4) Sender Palacio MJ, Vernet Vernet M, Pérez Lopez S, Faro Colomés M, Rojas Blanc M, Pallisa Gabril L. Enfermedad funcional tiroidea en la población de edad avanzada. Aten Primaria. 2004; 34(4): 192–7.
(5) Gaches F, Delaire L, Nadalon S, Loustaud–Ratt V, Vidal E. Frequency of autoimmune diseases in 218 patients with autoimmune thyroid pathologies. Rev Med Interne. 1998; 19: 173–9.
(6) Weetman AP. Autoimmune thyroiditis: predisposition and pathogenesis. Clin Endocrinol (Oxf). 1992; 36(4): 307–23.
(7) Zárate A, Basurto L, Saucedo R y Hernandez Valencia M. Enfermedad tiroidea: un tema de revisión constante por el ginecólogo, por su frecuencia en las mujeres. Ginecol Obstet Mex. 2009; 77: 96–102.
(8) Hernandez Valencia M, Córdova Pérez N, Zárate A, Basurto L, Manuel Apolinar L, Ruiz M y Col. Modificación de la agudización de los síntomas de la menopausia e hipotiroidismo. Ginec Obstet Mex. 2008; 76(10): 571–5.
(9) Schindler AE. Thyroid function and postmenopause. Gynecol Endocrinol. 2003; 17(1): 79–85.
(10) Zárate A, Basurto L, Hernández–Valencia M. Los trastornos tiroideos en la mujer. Ginecol Obstet Mex. 2001; 69: 200–5.
(11) Völzke H, Schwahn C, Wallaschofski H, Dörr M. Review: The association of thyroid dysfunction with all–cause and circulatory mortality: is there a causal relationship? J Clin Endocrinol Metab. 2007; 92(7): 2421–9.
(12) Razvi S, Shakoor A, Vanderpump M, Weaver JU, Pearce SH. The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a metaanalysis. J Clin Endocrinol Metab. 2008; 93(8): 2998–3007.
(13) Kim SK, Kim SH, Park KS, Park SW, Cho YW. Regression of the increased common carotid artery–intima media thickness in subclinical hypothyroidism after thyroid hormone replacement. Endocr J. 2009; 56(6): 753–8.
(14) Wolf M, Weigert A, Kreymann G: Body composition and energy expenditure in thyroidectomized patients during shortterm hypothyroidism and thyrotropinsuppressive thyroxine therapy. Eur J Endocrinol. 1996; 134: 168–73.
(15) Seppel T, Kosel A, Schlaghecke R. Bioelectrical impedance assessment of body composition in thyroid disease. Eur J Endocrinol. 1997; 136(5): 493–8.
(16) Torresani ME, Oliva ML, Echevarría C, Rossi ML, Maffei L. Perfil Antropométrico de Mujeres Perimenopáusicas. Rev Esp Nutr Comunitaria. 2007; 13(1): 6–10.
(17) Pavon de Paz C, Alameda H y Roldan JO. Obesidad y Menopausia. Nutr Hosp. 2006; 21(6): 633–7.
(18) Torresani ME, Oliva ML, Echevarría C, Rossi ML, Maffei L. Factores predictores de la ganancia de peso corporal a partir de la menopausia. En prensa.
(19) (US) NOEIEP on the I Evaluation, and Treatment of Obesity in Adults. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. National Heart, Lung, and Blood Institute; 1998.
(20) World Health Organization. Report of a WHO Scientific Group: Research on the Menopause in the 1990's. Geneva, Switzerland: World Health Organization. WHO Technical report Series 866; 1996.
(21) World Health Organization (WHO). The Health Benefits of Physical Activity in Developing Countries; Geneva: WHO; 2005.
(22) Weetman AP. Hypothyroidism: screening and subclinical disease. BMJ. 1997; 314(7088): 1175–8.
(23) Karlin NJ, Weintraub N, Chopra IJ. Current controversies in endocrinology: screening of asymptomatic elderly for subclinical hypothyroidism. J Am Med Dir Assoc. 2004; 5(5): 333–6.
(24) Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev. 2008; 29(1): 76–131.
(25) Reinehr T. Obesity and thyroid function. Mol Cell Endocrinol. 2010; 316(2): 165–71.
(26) Iacobellis G, Ribaudo MC, Zappaterreno A, Iannucci CV, Leonetti F. Relationship of thyroid function with body mass index, leptin, insulin sensitivity and adiponectin in euthyroid obese women. Clin Endocrinol (Oxf). 2005; 62(4): 487–91.
(27) Yen PM. Physiological and molecular basis of thyroid hormone action. Physiol Rev. 2001; 81(3): 1097–142.
(28) Peeters RP, van der Deure WM, van den Beld AW, van Toor H, Lamberts SW, Janssen JA, et al. The Asp727Glu polymorphism in the TSH receptor is associated with insulin resistance in healthy elderly men. Clin Endocrinol (Oxf). 2007; 66(6): 808–15.
(29) Fox CS, Pencina MJ, D'Agostino RB, Murabito JM, Seely EW, Pearce EN, et al. Relations of thyroid function to body weight: cross–sectional and longitudinal observations in a community based sample. Arch Intern Med. 2008; 168(6): 587–92.
(30) Waterhouse DF, McLaughlin AM, Walsh CD, Sheehan F, O'Shea D. An examination of the relationship between normal range thyrotropin and cardiovascular risk parameters: a study in healthy women. Thyroid. 2007; 17(3): 243–8.
(31) De Pergola G, Ciampolillo A, Paolotti S, Trerotoli P, Giorgino R. Free triiodothyronine and thyroid stimulating hormone are directly associated with waist circumference, independently of insulin resistance, metabolic parameters and blood pressure in overweight and obese women. Clin Endocrinol (Oxf). 2007; 67(2): 265–9.
(32) Westerink J, van der Graaf Y, Faber DR, Visseren FL; SMART study group. The relation between thyroid–stimulating hormone and measures of adiposity in patients with manifest vascular disease. Eur J Clin Invest. 2011; 41(2): 159–66.
(33) Pines A, Dotan I, Tabori U, Villa Y, Mijatovic V, Levo Y, Ayalon D. L–thyroxine prevents the bone–conserving effect of HRT in postmenopausal women with subclinical hypothyroidism. Gynecol Endocrinol. 1999; 13(3): 196–201.
(34) Verma A, Jayaraman M, Kumar HK, Modi KD. Hypothyroidism and obesity. Cause or effect? Saudi Med J. 2008; 29(8): 1135–8.
This journal 